Latest news, reports, and more from the RedChip Nation.
 
Discovering Tomorrow's Blue Chips Today
June 3, 2021     Contact    
Featured This Week
 
Amesite Launches Services on Microsoft Azure
 

 


Amesite Inc. (Nasdaq: AMST), a high-tech artificial intelligence software company offering a cloud-based learning platform and content creation services for business, university and K-12 learning and upskilling, announced its launch of services on Microsoft Azure. Running on Azure and in partnership with universities, Amesite is well-positioned to drive digital transformation and upskill professionals across markets. Microsoft puts real resources behind its Partners, offering not only engineering resources to migrate service to Azure, but multiple sales, marketing and data support to drive revenue for its Partners. As a Microsoft Partner, over the next weeks and months, Amesite is expected to leverage these resources to build sales and revenues. Microsoft’s Tamer Erzurumlu, Director of Partner Strategy for Education, said "By empowering Amesite and putting their platform on Microsoft Azure, we can approach our partner universities around the country and get these solutions out to people who need upskilling courses.”

 
 >
Latest News
 
Annovis Bio (NYSE American: ANVS) Announces Closing of $50 Million Public Offering at $50 per Share
 >
Annovis Bio (NYSE American: ANVS) Engages Global Executive Search Leader Spencer Stuart to Expand its Board and Management Team
 >
Virios Therapeutics (NASDAQ: VIRI) Announces Oral Presentation of Clinical Data at Digestive Disease Week® (DDW)
 
 
Nano Dimension (NASDAQ: NNDM) Launches DragonFly LDM® 2.0 Update
 
 
Aptorum Group (NASDAQ: APM) Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma
 
 
Aptorum Group (NASDAQ: APM) CEO Buys Shares in the Company
 
 
Kiromic (NASDAQ: KRBP) Announces FDA IND Submission First-In-Human, AI derived Off-The-Shelf IsoMesothelin Gamma Delta CAR T-cell Therapy, 30 Days Before the End of the Second Quarter
 
 
1847 Goedeker (NYSE American: GOED) Announces Pricing of $205 Million Public Offering
 
 
Tiziana Life Sciences (NASDAQ: TLSA) Announces Initiation of Clinical Trial in a Secondary Progressive Multiple Sclerosis (SPMS) Patient with Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, Under an Individual Patient Expanded Access Program
 
 
Tiziana Life Sciences (NASDAQ: TLSA) Reports Data Indicating Significant Immunomodulation effects on Immune and Inflammatory Biomarkers with Nasally Administered Foralumab in Healthy Volunteers
 
 
Hoth Therapeutics (NASDAQ: HOTH) Announces Participation at the American Society of Clinical Oncology (ASCO) Annual Meeting
 
 
Recruiter.com (OTCQB: RCRT) Partners with Karmacheck, LinkedIn Co-Founder Eric Ly's Latest Venture Focused on Reimagining the Candidate Background Check Experience
 
 
Esports Entertainment Group (NASDAQ: GMBL) New Jersey Gaming License Application Accepted by the NJ DGE
 
 
Esports Entertainment Group (NASDAQ: GMBL) to Add Swedish and Spanish-Licensed Gaming Business with Acquisition of Bethard
 
 
Cleveland Cavaliers Team Up With Esports Entertainment Group (NASDAQ: GMBL) to Become Official Esports Tournament Platform Provider in Multi-Year Deal
 
 
Esports Entertainment Group (NASDAQ: GMBL) Announces Private Placement of $35 Million Convertible Notes with $17.50 Conversion Price
 
 
Draganfly (OTCQB: DFLY) Announces Record Revenue in First Quarter of 2021
 
 
DSS (NYSE American: DSS) Expands Footprint of DSS Securities through Acquisition of 24.9% of Broker-Dealer Sentinel Brokers Company
 
 
Elys Game Technology (NASDAQ: ELYS) Chairman Michele Ciavarella Appeared on Varney & Co. on Fox Business Network
 
 
Vision Marine Technologies (NASDAQ: VMAR) Appoints Globally Respected Cleantech Entrepreneur and Financier Alan Gaines to its Board
 
 
Hut 8 Mining (OTCQB: HUTMF) Advances High-Performance Computing Capabilities with Procurement of Tier 1 Server Hardware
 
 
CBD of Denver’s (OTC: CBDD) Expands Wholesale Business Through New Contract with One of the Largest Swiss Producers
 
 
CBD of Denver (OTC: CBDD) Expands its Swiss Production with New Company-Owned Extraction and Washdown Facility
 
 
 
Upcoming Zoom Webinar
 

Join Zoom Meeting: zoom.us/j/96167215347
One tap mobile : US:
+13017158592,,96167215347#,,,,*647105#
or +13126266799,,96167215347#,,,,*647105#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 961 6721 5347
Passcode: 647105
International numbers available:
zoom.us/u/acEoJXL59b


 
 
 
 
 

Join Zoom Meeting: zoom.us/j/96829272926
Or iPhone one-tap : US: +13126266799,,96829272926#,,,,*626161#
or +16465588656,,96829272926#,,,,*626161#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 968 2927 2926
Passcode: 626161
International numbers available:
zoom.us/u/abrZPF7zKL


 
 
 
 

Join Zoom Meeting: zoom.us/j/99378274367
Or iPhone one-tap : US: +13126266799,,99378274367#,,,,*830331#
or +16465588656,,99378274367#,,,,*830331#
Dial(for higher quality, dial a number based on your current location):
+1 646 558 8656 US (New York)
+1 301 715 8592 US (Washington D.C)
+1 312 626 6799 US (Chicago)
+1 669 900 9128 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)

Webinar ID: 993 7827 4367
Passcode: 830331
International numbers available:
zoom.us/u/apyAwvPum


 
 
 
 
 
 
 
Quote of the Week
 
"It’s harder and always takes longer than you anticipate."
- Manny Villafana, Founder of St. Jude Medical
 
 
 
Lesson of the Week
 
Look for companies with low PE ratios.
Read More
 
 
 

 

Latest Videos
 
 
This Week on RedChip TV: 2 Innovative Small-Cap Stocks & a Leading Fund Manager
 
This week’s episode of the RedChip Money Report features interviews with two innovative small-cap stocks, Elise Gaming Technology (NASDAQ: ELSI), targeting B2B and B2C gaming and sports betting opportunities with proprietary technology, and Can-Fite BioPharma (NYSE American: CANF), an advanced clinical stage biopharma with a compelling pipeline and multiple licensing agreements that could generate $140 million in milestone payments plus ongoing royalties. This week’s episode also features an exclusive interview with Christopher Krug, a leading small-cap investment manager. Visit RedChip.com to learn more.
 
Watch Now
 
 
 
 
Can-Fite BioPharma: Robust Pipeline Includes 75% Enrolled Phase 3 Psoriasis Program
 
Can-Fite BioPharma (NYSE Amerian:CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19. The Company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis and a Phase II study in the treatment of moderate COVID-19. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and successfully achieved its primary endpoint in a Phase II trial for the treatment of non-alcoholic steatohepatitis (NASH).
 
Watch Now
 
 
 
 
Hoth Therapeutics: Developing New Therapies for Unmet Medical Needs
 
Hoth Therapeutics (Nasdaq: HOTH) is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. Hoth's pipeline development is focused to improve the quality of life for patients suffering from indications including atopic dermatitis, skin toxicities associated with cancer therapy, chronic wounds, psoriasis, asthma, acne, mast-cell derived cancers & anaphylaxis and pneumonia.
 
Watch Now
 
 
 
 
Killi: Transforming the $247B Market for Personal Data
 
Founded in 2018 and with offices in New York & Toronto, Killi (TSXV: MYID; OTCQB: MYIDF) is a company driven by the evolution of data and privacy. Killi aims to democratize data for consumers by providing them with an ecosystem where they can view, edit, opt-out, and be compensated for the use of their data.
 
Watch Now
 
 
 
 
American Resources: Raw Materials for the New Infrastructure Market
 
American Resources Corp. (Nasdaq: AREC) is a next-generation, environmentally and socially responsible supplier of high-quality raw materials to the new infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical rare earth minerals for the electrification market, and reprocessed metal to be recycled.
 
Watch Now
 
 
 
 
Genetic Technologies: Expanding Portfolio of Disease Risk Tests
 
Genetic Technologies (Nasdaq: GENE) is a diversified molecular diagnostics company developing tools for the prediction and assessment of cancer risk to help physicians proactively manage patient health. The Company’s lead products, ‘GeneType for Breast Cancer’ and ‘GeneType for Colorectal Cancer’, are clinically validated risk assessment tests that are first in their class.
 
Watch Now
 
 
 
 
Milestone Scientific: Leading Injection Technology Innovator
 
Milestone Scientific (NYSE American: MLSS) is a leading medical research and development company that designs and patents innovative injection technology. The Company’s clinically validated, patented, computer-controlled systems make injections precise, efficient, and virtually painless, addressing unmet needs and providing a potential new standard of care in anesthesia.
 
Watch Now
 
 
 
 
iMetal Resources: Exploring for Gold in Eastern Canada
 
iMetal Resources (OTC: ADTFF) is a Canadian based junior exploration company focused on the exploration and development of its portfolio of resource properties in Ontario and Quebec. iMetal is focused on advancing its Gowganda West Project that borders Caldas Gold Corp’s 2.2 million ounce Juby Project, an advanced exploration-stage gold project located within the Shining Tree area in the southern part of the Abitibi greenstone belt about 100 km south-southeast of the Timmins gold camp.
 
Watch Now
 
 
 
 
Palisade Bio: Phase 2/3 Ready Drug Candidate Entering Trials 2H 2021
 
Palisade Bio (Nasdaq: PALI) is developing novel therapeutics designed to improve human health through therapeutic protection of the gastrointestinal (GI) mucosal barrier. PALI’s initial focus is combatting the interruption of GI function (ileus) following major surgery in order to accelerate recovery times and shorten the duration of patient hospital stays.
 
Watch Now
 
 
 
 
DeFi Technologies: Transforming the Global Financial System
 
Led by co-founders Wouter Witvoet and Olivier Roussy Newton, who collectively raised $1.4B in their prior two deals, DeFi Technologies (OTC: DEFTF) is well positioned to become a key player in the rapidly growing decentralized finance industry. The market size for the industry is measured in the trillions and spans multiple sectors, including insurance, derivatives, credit and lending, asset management, and exchanges.
 
Watch Now
 
 
 
 
Amesite: AI-Driven EdTech Transforming Learning
 
Amesite (Nasdaq: AMST) is an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education. The Company leverages existing institutional infrastructures, adding mass customization and cutting-edge technology to provide cost-effective, scalable, and engaging experiences for learners anywhere.
 
Watch Now
 
 
 
 
CBD of Denver Interviewed on Benzinga’s Cannabis Insider
 
CBD of Denver (CBDD) is a full-line CBD and hemp oil company, producing and distributing cannabis and CBD products in Switzerland, Europe, and the US. CBDD is focused on using equity to acquire profitable Swiss assets at attractive valuations to create value for its shareholders and is driven by a passion to improve lives and strengthen communities by unleashing the full potential of cannabis.
 
Watch Now
 
 
 
 
Tiziana Life Sciences: Robust Pipeline with Multiple Near-Term Catalysts
 
Tiziana Life Sciences (NASDAQ: TLSA) has developed proprietary oral, nasal, and inhaled formulation technologies that could transform immunotherapies with Monoclonal Antibodies currently administered intravenously for multiple indications.
 
Watch Now
 
 
 
 
Medalist Diversified REIT: Targeting Attractive Opportunities in Secondary Markets in Southeast U.S.
 
Medalist Diversified REIT (NASDAQ: MDRR) was founded in 2003 as a private equity company specializing in acquiring, owning, and managing commercial real estate in the Southeast. The Company’s strategy is to focus on value-add and opportunistic commercial real estate which is expected to provide an attractive balance of risk and returns. Medalist utilizes a rigorous, consistent, and replicable process for sourcing and conducting due diligence of acquisitions.
 
Watch Now
 
 
 
 
Recruiter.com: Transforming the World of Recruiting
 
Recruiter.com (OTCQB: RCRT) is a hiring platform for the world’s largest network of recruiters. Recruiter.com empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize an innovative web platform, complete with AI-driven job matching, screening and video interviewing to recruit talent faster.
 
Watch Now
 
 
 
 
Virios Therapeutics: Potential Treatment Paradigm Shift for Fibromyalgia
 
Virios Therapeutics (Nasdaq: VIRI) is a clinical-stage biotechnology company focused on advancing novel, dual mechanism antiviral therapies to treat conditions associated with virally triggered or maintained immune responses, such as Fibromyalgia (“FM”).
 
Watch Now
 
 
 
 
Aptorum Group: Developing Novel Therapeutics for Unmet Medical Needs
 
Aptorum Group Limited (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum's current drug pipeline includes indications in orphan diseases, infectious diseases, and metabolic diseases.
 
Watch Now
 
 
 
 
EVmo: Leading Provider of Rental Vehicles for the Gig Economy
 
EVmo (OTC: YAYO) bridges the gap between rideshare drivers in need of a suitable vehicle and rideshare companies that depend on attracting and keeping drivers. EVmo uniquely supports drivers in both the higher and lower economic categories with innovative policies and programs. EVmo is a leading provider of rental vehicles to drivers in the ever-expanding gig economy.
 
Watch Now
 
 
 
 
BTCS: Pioneer in Blockchain Space
 
BTCS Inc. (OTCQB: BTCS) is an early entrant in the digital asset market and one of the first U.S. publicly traded companies focused on digital assets and blockchain technologies. BTCS resumed its transaction verification services business segment in the first quarter of 2021 with a focus on validating transactions and operating nodes on proof-of-stake blockchains.
 
Watch Now
 
 
 
 
Learn Why Robert Blair, The Visionary Architect Behind Lulu Lemon (LULU) Joined RYU Apparel
 
RYU Apparel (OTCQB: RYPPF), or Respect Your Universe, is an award winning urban athletic apparel brand that engages in the development, marketing, and distribution of apparel, bags and accessories. Our products are engineered for the fitness, training and performance of the multi-discipline athlete. Our products are designed, developed and tested at our corporate headquarters in Vancouver, BC, Canada. Production takes place in factories located in North America and Asia.
 
Watch Now
 
 
 
 
Lantern Pharma: Transforming Cancer Drug Development with A.I.
 
Lantern Pharma (Nasdaq: LTNR) is a clinical stage biotechnology company leveraging its RADR® artificial intelligence (“A.I.”) platform to transform the pace, risk and cost of oncology drug development. RADR® A.I. quickly and efficiently develops precise genetic signatures of disease that underpin the identification of patients for whom its portfolio of oncology drug candidates is likely to have the greatest therapeutic effect. Lantern is currently developing three drug candidates in solid tumors.
 
Watch Now
 
 
 
 
Kiromic BioPharma: AI-Driven Immuno-Oncology Therapy Development
 
Kiromic BioPharma (Nasdaq: KRBP) is revolutionizing next-generation allogenic CAR therapies for solid tumors. The Company’s proprietary target discovery engine, Diamond uses AI and a proprietary neural network to identify development targets, dramatically compressing man years and billions of drug development dollars required to develop new live drugs.
 
Watch Now
 
 
 
 
Order Small Stocks, Big Money Today!
 
Dave Gentry is the author of Small Stocks, Big Money: Interviews With Microcap Superstars. Published by Wiley, this first-hand perspective on the fast world of microcap investing is now available for purchase.
 
 
MidSouth Week in Review
 
Consumer confidence in the U.S. was unchanged in May, following four straight months of gains, signaling an optimistic view of the economy.
Read More
 
 
 
 
About RedChip
 
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on small-cap and mid-cap companies. Since 1992, RedChip has delivered concrete, measurable results for its clients through the most comprehensive service platform in the industry for small-cap and mid-cap companies. These services include a worldwide distribution network for its stock research written by analysts holding the CFA designation; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated over 2.3 million unique investor views; quarterly global online institutional and retail investor conferences that reach over 10,000 investors annually; "The RedChip Money Report" television show which airs in 100 million homes across the U.S. on The Family Channel; a weekly newsletter delivered to 60,000 investors; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.
 
RedChip Disclosure
 
RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.
RedChip Visibility is a division of RedChip Companies, Inc. and offers research services to paying clients. In the purview of Section 17(b) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention to the fact that the RedChip Companies Inc. is an investor relations firm hired by certain Companies to increase investor awareness to the small-cap equity community.
Stock market investing is inherently risky. RedChip Companies is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print.
We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission ("SEC") at www.sec.gov and view RedChip’s Disclosures.
 
 
     
 
 
Copyright © 2021 RedChip Companies, Inc. All Rights Reserved.
You are receiving this message because this email address has signed up to receive News Alerts.